Department of Pathology, Jinling Hospital Nanjing, Medical School, Nanjing University, China. yinhl1978@ yahoo.com.cn
Int J Surg Pathol. 2009 Jun;17(3):255-61. doi: 10.1177/1066896909334126.
This study retrospectively reviewed the clinicopathological features of thymic epithelial tumors in 108 patients, and evaluated World Health Organization (WHO) histologic classification of thymic tumors. Other prognostic factors, including age, gender, clinical stage, and completeness of tumor resection were also analyzed. Seven type A tumors, 19 type AB, 23 type B1, 19 type B2, 27 type B3, and 13 thymic carcinomas were studied. The 5-year and 10-year survival rates were 100% after resection of tumor types A and AB; 93% and 81% for B1; 83% and 70% for B2; and 43% and 33% for B3. The overall 5-year and 10-year survival rates were 72.0% and 63.0%, respectively. Tumor classification was highly significant in predicting survival (P .001) and also reflected the clinical behavior of tumors. The Masaoka stage was the most important independent prognostic index in thymomas. The WHO histologic subtype and completeness of resection were also important prognostic factors.
本研究回顾性分析了108例胸腺上皮肿瘤患者的临床病理特征,并评估了世界卫生组织(WHO)胸腺肿瘤组织学分类。还分析了其他预后因素,包括年龄、性别、临床分期和肿瘤切除的完整性。研究了7例A型肿瘤、19例AB型、23例B1型、19例B2型、27例B3型和13例胸腺癌。A型和AB型肿瘤切除后的5年和10年生存率为100%;B1型分别为93%和81%;B2型分别为83%和70%;B3型分别为43%和33%。总体5年和10年生存率分别为72.0%和63.0%。肿瘤分类在预测生存方面具有高度显著性(P<0.001),也反映了肿瘤的临床行为。Masaoka分期是胸腺瘤最重要的独立预后指标。WHO组织学亚型和切除完整性也是重要的预后因素。